載入...

β2-adrenoreceptor medications and risk of Parkinson disease

OBJECTIVE: A recent study observed a two-fold greater risk of Parkinson disease (PD) in relation to the β2-adrenoreceptor antagonist propranolol and a markedly lower risk of PD for the β2-adrenoreceptor agonist salbutamol. We examined whether confounding by clinical indication for these medications,...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ann Neurol
Main Authors: Nielsen, Susan Searles, Gross, Anat, Camacho-Soto, Alejandra, Willis, Allison W., Racette, Brad A.
格式: Artigo
語言:Inglês
出版: 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881195/
https://ncbi.nlm.nih.gov/pubmed/30225948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25341
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!